Multiple Myeloma: Diagnosis and Treatment.
Rajkumar SV et al. Mayo Clin Proc. 2016 Jan;91(1):101-19. doi: 10.1016/j.mayocp.2015.11.007.

Management of relapsed multiple myeloma: Recommendations of the international myeloma working group.
Laubach J et al. Leukemia. 2015 Dec 29. doi: 10.1038/leu.2015.356. [Epub ahead of print].

First hematopoietic cell transplantation in Uzbekistan: Progress through education and cooperation.
Karimov K et al. Transfus Apher Sci. 2016 Jan 12. pii: S1473-0502(16)00016-1. doi: 10.1016/j.transci.2016.01.014. [Epub ahead of print].

Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.
Vélez R et al. BMJ Open. 2016 Jan 21;6(1):e009584. doi: 10.1136/bmjopen-2015-009584.

Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.
Guillerey C et al. Cell Mol Life Sci. 2016 Jan 22. [Epub ahead of print].

The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution.
Bonomo L et al. Cancer Med. 2016 Jan 22. doi: 10.1002/cam4.620. [Epub ahead of print].

Autopsy Analysis may Contribute to Establish Actual Incidence of Second Primary Malignancies in Myeloma.
Takano J et al. Rare Tumors. 2015 Dec 29;7(4):5949. doi: 10.4081/rt.2015.5949. eCollection 2015.

Multiple myeloma: Diagnosis and management issues in patients with pre-existing chronic kidney disease.
Vadlamudi S et al. Saudi J Kidney Dis Transpl. 2016 Jan-Feb;27(1):9-14. doi: 10.4103/1319-2442.174046.

The Role of Immunotherapy in Multiple Myeloma.
Kocoglu M et al. Pharmaceuticals (Basel). 2016 Jan 14;9(1). pii: E3. doi: 10.3390/ph9010003.

Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF et al. Acta Oncol. 2016 Jan 19:1-10. [Epub ahead of print].

Hematologic malignancies in South Africa 2000-2006: analysis of data reported to the National Cancer Registry.
Schonfeld SJ et al. Cancer Med. 2016 Jan 15. doi: 10.1002/cam4.597. [Epub ahead of print].

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).
Bruno B et al. Leuk Lymphoma. 2016 Jan 6:1-13. [Epub ahead of print].

Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity.
Cornell RF et al. Bone Marrow Transplant. 2016 Jan 4. doi: 10.1038/bmt.2015.307. [Epub ahead of print].

Allogeneic stem cell transplantation for multiple myeloma: is there a future?
Dhakal B et al. Bone Marrow Transplant. 2016 Jan 4. doi: 10.1038/bmt.2015.325. [Epub ahead of print]